BiTE by BiTE: evolving blood cancer therapies
Cancer BiTE Immunotherapy

BiTE by BiTE: evolving blood cancer therapies

Dr. Talia Henkle
Dr. Talia Henkle

In 10 seconds? Bi-specific T cell engagers, or BiTEs, are cutting-edge cancer treatments that are having success in treating some types of blood cancers. Exciting new data on next-generation formulations of these treatments show their promise.

That’s a lot of fancy words. What are BiTEs? They are ingenious products of cellular engineering and are emerging stars in cancer immunotherapies (AKA treatments that boost our immune system to kill cancer). Immunotherapies like BiTEs rely on immune cells called T cells–some of which can be activated to kill cancer under certain conditions.


Get unlimited access to our 3-min Digests and other premium features!

Choose your plan:

Personal

$39/quarter
  • Includes 7-day free trial
  • Unlimited access to Sparrow
  • Access all citations and resources
  • Gain background knowledge with a Quick Dive
  • Daily newsletter
  • Weekly Recap
  • The Sparrow Sessions Podcast
  • No ads

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Personal

$99/year
  • Save 36% in one, easy payment
  • Includes 7-day free trial
  • Unlimited access to Sparrow
  • Access all citations and resources
  • Gain background knowledge with a Quick Dive
  • Daily newsletter
  • Weekly Recap
  • The Sparrow Sessions Podcast
  • No ads

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

Custom Pricing

  • Everything in Personal
  • Direct access to the Expert Network
  • Your questions - answered by an Expert Scientist
  • 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
Contact us